Tumors of the Central Nervous System, Volume 12 (Record no. 93968)

000 -LEADER
fixed length control field 05767nam a22004695i 4500
001 - CONTROL NUMBER
control field 978-94-007-7217-5
003 - CONTROL NUMBER IDENTIFIER
control field DE-He213
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20140220082530.0
007 - PHYSICAL DESCRIPTION FIXED FIELD--GENERAL INFORMATION
fixed length control field cr nn 008mamaa
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 131112s2014 ne | s |||| 0|eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9789400772175
-- 978-94-007-7217-5
024 7# - OTHER STANDARD IDENTIFIER
Standard number or code 10.1007/978-94-007-7217-5
Source of number or code doi
050 #4 - LIBRARY OF CONGRESS CALL NUMBER
Classification number RC261-271
072 #7 - SUBJECT CATEGORY CODE
Subject category code MJCL
Source bicssc
072 #7 - SUBJECT CATEGORY CODE
Subject category code MED062000
Source bisacsh
082 04 - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 614.5999
Edition number 23
100 1# - MAIN ENTRY--PERSONAL NAME
Personal name Hayat, M.A.
Relator term editor.
245 10 - TITLE STATEMENT
Title Tumors of the Central Nervous System, Volume 12
Medium [electronic resource] :
Remainder of title Molecular Mechanisms, Children's Cancer, Treatments, and Radiosurgery /
Statement of responsibility, etc edited by M.A. Hayat.
264 #1 -
-- Dordrecht :
-- Springer Netherlands :
-- Imprint: Springer,
-- 2014.
300 ## - PHYSICAL DESCRIPTION
Extent XLVIII, 386 p. 64 illus., 55 illus. in color.
Other physical details online resource.
336 ## -
-- text
-- txt
-- rdacontent
337 ## -
-- computer
-- c
-- rdamedia
338 ## -
-- online resource
-- cr
-- rdacarrier
347 ## -
-- text file
-- PDF
-- rda
490 1# - SERIES STATEMENT
Series statement Tumors of the Central Nervous System,
International Standard Serial Number 2215-096X ;
Volume number/sequential designation 12
505 0# - FORMATTED CONTENTS NOTE
Formatted contents note Preface. I Molecular mechanisms -- Classification/diagnosis of brain tumors using discriminate function analysis -- Neuronal differentiation in the adult brain: cdk6 as the molecular regulator -- Prolactinomas: role of vegf, fgf-2 and cd31 -- Human brain tumor growth: role of aquaporins -- Molecular and functional characterization of human adipocytes -- II Children’s cancer -- Inhibition of neuroblastoma progression by targeting Lymphangiogenesis: role of an endogenous soluble splice-variant of vegfr-2 -- Hyperinsulinemia tends to induce growth without growth hormone in children with brain tumors after neurosurgery -- Childhood brain tumors: proton beam therapy -- Pathogenesis of medulloblastoma: role of molecular genetic alterations -- Medulloblastomas: survival differences between children and adults -- Survivors of childhood cancer: risk of glioma and meningioma following radiotherapy -- Survivors of childhood cancer: risk of new primary neoplasms of the cns.-III Treatments -- Brain tumor typing and therapy using combined ex vivo magnetic resonance spectroscopy and molecular genomics -- Atlas-based segmentation of tumor-bearing brain images -- Nonthermal irreversible electroporation as a focal ablation treatment for brain cancer -- The role of whole brain radiation therapy for metastatic brain tumors -- Craniotomy for intracranial tumors: role of postoperative hematoma in surgical mortality -- Pituitary adenomas: treatment using the endonasal approach intracranial tumors: treatment with endoscopic neurosurgery -- Incidence of recraniotomy for postoperative infections after surgery for intracranial tumors -- Transsphenoidal surgery for non-adenomatous tumors: effect on pituitary function -- Treatment of brain tumors: electrochemotherapy -- Comparison of navigated transcranial magnetic stimulation to direct electrical stimulation for mapping the motor cortex prior to brain tumor resection -- The role of glutathione and the glutathione-linked enzyme systems in brain tumor drug resistance -- Drugs for primary brain tumors: an update -- Neurosurgical treatment for brain metastases: clinical features, operative strategies, recurrence, and survival. IV Radiosurgery -- Image-guided radiosurgery for hypothalamic hamartomas -- Image-guided stereotactic radiosurgery for spinal pathology -- Image guided stereotactic radiosurgery for optic nerve sheath meningiomas -- Brain metastases: the application of stereotactic radiosurgery and technological advances -- Treatment of chordomas by stereotactic radiosurgery with a linear accelerator: comparison with other modes. Index.
520 ## - SUMMARY, ETC.
Summary, etc As in the case of its eleven predecessors in the series Tumors of the Central Nervous System, this volume is distinguished for its thorough approach, its roster of 92 distinguished contributors representing 11 different countries and its detailed examination of leading-edge technology and methods. Volume 12: Molecular Mechanisms, Children’s Cancer, Treatments, and Radiosurgery offers a comprehensive review of the diagnosis, therapy and prognosis of brain and spinal cord tumors. Coverage extends to a large number of tumor types, including neuroblastoma, medulloblastoma, meningioma and chordoma. Molecular profiling of brain tumors to select appropriate therapy in clinical trials of brain tumors is discussed in detail, as is the classification/diagnosis of brain tumors based on function analysis. CDK6 as the molecular regulator of neuronal differentiation in the adult brain, and the role of aquaporins in human brain tumor growth are explained. Discussion also includes tumors affecting children, including neuroblastoma and medulloblastoma. A full chapter is devoted to the role of molecular genetic alterations in medulloblastoma, and another examines survival differences between children and adults with medulloblastoma. The use of various types of imaging methods to diagnose brain tumors is explained. In-depth discussion of treatment options includes stereotactic radiosurgery, endoscopic neurosurgery, electrochemotherapy, transsphenoidal surgery, focal ablation, whole brain radiation therapy and recraniotomy.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Medicine.
650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Oncology.
650 14 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Biomedicine.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Cancer Research.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Oncology.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Biomedicine general.
650 24 - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Medicine/Public Health, general.
710 2# - ADDED ENTRY--CORPORATE NAME
Corporate name or jurisdiction name as entry element SpringerLink (Online service)
773 0# - HOST ITEM ENTRY
Title Springer eBooks
776 08 - ADDITIONAL PHYSICAL FORM ENTRY
Display text Printed edition:
International Standard Book Number 9789400772168
830 #0 - SERIES ADDED ENTRY--UNIFORM TITLE
Uniform title Tumors of the Central Nervous System,
-- 2215-096X ;
Volume number/sequential designation 12
856 40 - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier http://dx.doi.org/10.1007/978-94-007-7217-5
912 ## -
-- ZDB-2-SME

No items available.

2017 | The Technical University of Kenya Library | +254(020) 2219929, 3341639, 3343672 | library@tukenya.ac.ke | Haile Selassie Avenue